MESA LABORATORIES Releases Fourth Quarter FY2023 Earnings Results for March 31 2023

🌥️Earnings Overview

MESA LABORATORIES ($NASDAQ:MLAB) released its financials for the fourth quarter of FY2023 (ending March 31, 2023) on May 25, 2023. Despite a 5.6% year-over-year decrease in total revenue to USD 55.6 million, net income surged 134.3% year-over-year to USD 0.61 million.

Stock Price

On Thursday, MESA LABORATORIES released their fourth quarter FY2023 earnings results for March 31 2023. The company’s stock opened at $146.9 and closed at $141.1, representing a decline of 2.0% from its last closing price of 143.9. Overall, MESA LABORATORIES’ fourth quarter FY2023 earnings results show a positive outlook for the company. Despite experiencing a slight decline in its closing price on Thursday, the company’s revenue and net income have grown steadily over the past year, indicating that the company is on track for further success in the future. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Mesa Laboratories. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Mesa Laboratories. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Mesa Laboratories. More…

Key Ratios Snapshot

Some of the financial key ratios for Mesa Laboratories are shown below. More…

Analysis

GoodWhale has analyzed MESA LABORATORIES‘ financials and found that it is a high risk investment. Our Risk Rating indicates that there are potential issues in terms of both financial and business aspects. Upon further inspection, GoodWhale has detected 5 risk warnings in the company’s income statement, balance sheet, cashflow statement, non-financial, and financial journal. We invite our registered users to look into these findings in more detail. Our proprietary analytics engine allows investors to identify red flags and other potential risks that could affect their investments. With GoodWhale, you can make informed decisions on your investments with confidence. More…

Peers

The company’s products include blood gas analyzers, centrifuges, and incubators. Mesa Laboratories Inc’s competitors include CurAegis Technologies Inc, Biome Technologies PLC, PipeHawk PLC.

– CurAegis Technologies Inc ($LSE:BIOM)

Biome Technologies PLC is a British biotechnology company based in Southampton. The company’s core business is the development and commercialisation of sustainable technologies for the food, agriculture and energy industries. The company has a market cap of 1.86M and a ROE of -24.52%. The company’s products include anaerobic digestion systems, algal oils, enzymes and biopolymers. The company’s products are used in a variety of applications including food processing, animal feed, waste management and renewable energy.

– Biome Technologies PLC ($LSE:PIP)

PipeHawk PLC is a provider of pipe inspection and condition assessment services. The company has a market capitalization of 5.27 million as of 2022 and a return on equity of -3.7%. PipeHawk PLC provides services to a variety of industries including oil and gas, water and sewer, and power generation. The company’s services are used to inspect and assess the condition of pipelines and other infrastructure.

Summary

MESA LABORATORIES reported its fourth quarter results for FY2023 on May 25 2023. Total revenue decreased 5.6% year-over-year to USD 55.6 million, however, net income rose 134.3% year-over-year to USD 0.61 million. This positive earnings result indicates that MESA LABORATORIES may present an attractive investment opportunity. Investors should be aware, however, that the company’s revenue is down from the previous year and that future earnings must be monitored for any signs of a potential decline in performance.